Isolated Systolic Hypertension in the Elderly

Area of Science:

• Cardiology
• Geriatrics
• Internal Medicine

Background:

• Isolated systolic hypertension (ISH) is the most common hypertension type in individuals over 50.
• Systolic blood pressure (SBP) is a stronger predictor of cardiovascular risk and mortality than diastolic blood pressure (DBP).
• Current clinical practice is less aggressive and successful in controlling SBP compared to DBP.

Purpose of the Study:

• To emphasize the importance of SBP as the primary criterion for diagnosing, staging, and managing hypertension in older adults.
• To review evidence supporting the benefits of treating ISH in the elderly.
• To discuss the role of lifestyle modifications and specific antihypertensive agents in managing ISH.

Main Methods:

• Review of recent large, randomized, placebo-controlled trials on ISH drug therapy in the elderly.
• Analysis of the impact of lifestyle modifications (salt restriction, physical activity) on arterial compliance and ISH control.
• Evaluation of antihypertensive drug classes for their efficacy in reducing SBP.

Main Results:

• Numerous trials demonstrate significant reductions in cardiovascular events and mortality with ISH drug therapy.
• Lifestyle modifications show potential for improving arterial compliance and managing ISH.
• Most antihypertensive agents effectively lower SBP, with ACE inhibitors and nitrates offering particular advantages for ISH.

Conclusions:

• SBP should be the primary focus for hypertension diagnosis, staging, and treatment in older individuals.
• Treatment of ISH, incorporating lifestyle changes and appropriate pharmacotherapy, is crucial for reducing cardiovascular morbidity and mortality.
• Specific drug classes may offer superior benefits for managing ISH in the elderly.